{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:12:50Z","timestamp":1782832370648,"version":"3.54.5"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:p>This case report describes a patient with immune checkpoint inhibitor\u2013associated bullous pemphigoid and preexisting anti-BP180\u2013C-terminus antibodies.<\/jats:p>","DOI":"10.1001\/jamadermatol.2024.6665","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:00:38Z","timestamp":1744210838000},"page":"557","source":"Crossref","is-referenced-by-count":7,"title":["Epitope Spreading in Immune Checkpoint Inhibitor\u2013Associated Bullous Pemphigoid"],"prefix":"10.1001","volume":"161","author":[{"given":"Hiroshi","family":"Koga","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwesi","family":"Teye","sequence":"additional","affiliation":[{"name":"Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Shirahama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Azuma","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takekuni","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9863","key":"dlo240025r1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases.","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"dlo240025r2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953546","article-title":"Hemidesmosomal reactivity and treatment recommendations in immune checkpoint inhibitor-induced bullous pemphigoid\u2014a retrospective, monocentric study.","volume":"13","author":"Schauer","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"dlo240025r3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/path.6220","article-title":"Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A\/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.","volume":"262","author":"Pigors","year":"2024","journal-title":"J Pathol"},{"issue":"2","key":"dlo240025r4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaad.2019.04.029","article-title":"Nonbullous pemphigoid: insights in clinical and diagnostic findings, treatment responses, and prognosis.","volume":"81","author":"Lamberts","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"dlo240025r5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2016.06.019","article-title":"IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.","volume":"73","author":"Zuo","year":"2016","journal-title":"J Autoimmun"},{"issue":"4","key":"dlo240025r6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jaad.2019.08.045","article-title":"BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors.","volume":"82","author":"Hasan Ali","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2832484\/jamadermatology_koga_2025_lo_240025_1747728365.88786.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:00:27Z","timestamp":1747839627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2832484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.6665","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}